Association of serum homocysteine levels with the severity and calcification of coronary atherosclerotic plaques detected by coronary CT angiography

International Angiology

Volumn 33, Issue 4, 2014, Pages 316-323

  Sun, Q ^a,b   Jia, X ^a   Gao, J ^a   Mou, W ^a   Tong, H ^a   Wen, X ^a   Tian, Y ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHENGDE MEDICAL COLLEGE   (China)

Author keywords

Angiography; Atherosclerosis; Coronary artery disease; Homocysteine; Tomography, X ray computed

Indexed keywords

BILIRUBIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; RISK ASSESSMENT; SMOKING; AGED; BLOOD; BLOOD VESSEL CALCIFICATION; BRAIN ANGIOGRAPHY; CHI SQUARE DISTRIBUTION; CORONARY BLOOD VESSEL; CROSS-SECTIONAL STUDY; PROCEDURES; RADIOGRAPHY; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; AGED; BIOLOGICAL MARKERS; CEREBRAL ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR CALCIFICATION;

EID: 84923321033     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Curr Probi Cardiol. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probi Cardiol 2010;35:72-115.
2. Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med 2013;11:117.
3. Chopra V, Eagle KA. Cardiac biomarkers in the diagnosis, prognosis and management of coronary artery disease: a primer for internists. Indian J Med Sci 2010;64:561-73.
4. Ni M, Zhang XH, Jiang SL, Zhang Y. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease. Am J Cardiol 2007;100:455-8.
5. Wu Y, Huang Y, Hu Y, Zhong J, He Z, Li W et al. Hyper-homocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China. Herz 2013 [Epub ahead of print].
6. Debreceni B, Debreceni L. Why do homocysteine-lower-ing B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc Ther 2012;30:227-33.
7. Marti-Carvajal AJ, Sola I, Lathyris D, Karakitsiou DE, Simancas-Racines D. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2013;1:CD006612.
8. Chai HT, Chen YL, Chung SY, Tsai TH, Yang CH, Chen HC et al. Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study. Int Heart J 2011;52:280-5.
9. Wu Y, Yang L, Zhong L. Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity. Atherosclerosis 2010;212:351-5.
10. Faria-Neto JR, Chagas AC, Bydlowski SP, Lemos Neto PA, Chamone DA, Ramirez JA et al. Hyperhomocystinemia in patients with coronary artery disease. Braz J Med Biol Res 2006;39:455-63.
11. Boogers M J, Broersen A, van Velzen JE, de Graaf FR, El-Naggar HM, Kitslaar PH et al. Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J 2012;33:1007-16.
12. Gao D, Ning N, Guo Y, Ning W, Niu X, Yang J. Computed tomography for detecting coronary artery plaques: a meta-analysis. Atherosclerosis 2011;219:603-9.
13. Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O'Malley PG. Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J 2001;141:463-8.
14. Kullo IJ, Li G, Bielak LF, Bailey KR, Sheedy PF 2nd, Peyser PA et al. Association of plasma homocysteine with coronary artery calcification in different categories of coronary heart disease risk. Mayo Clin Proc 2006;81:177-82.
15. Von Feldt JM, Scalzi LV, Cucchiara AJ, Morthala S, Kea-ley C, Flagg SD et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum 2006;54:2220-7.
16. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:390-419.
17. Miller JM, Dewey M, Vavere AL, Rochitte CE, Niinuma H, Arbab-Zadeh A et al. Coronary CT angiography using 64 detector rows: methods and design of the multicentre trial CORE-64. Eur Radiol 2009;19:816-28.
18. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e) inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
19. Seihub J, Jacques PF, Bostom AG, DAgostino RB, Wilson PW, Belanger AJ et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
20. Malinow MR, Bostom AG, Krauss RM. Homocyst(e) ine, diet, and cardio-vascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
21. Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC et al. Homocysteine and reclassification of cardiovascular disease risk. Am Coll Cardiol 2011;58:1025-33.
22. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:496-507.
23. de Lemos JA, Lloyd-Jones DM. Multiple biomarker panels for cardiovascular risk assessment. N Engl J Med 2008;358:2172-4.
24. Ma Y, Li L, Shang XM, Tan Z, Geng XB, Zhao BQ et al. Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Exp Ther Med 2013;5:1206-10.
25. Nagele P, Meissner K, Francis A, Födinger M, Saccone NL. Genetic and environmental determinants of plasma total homocysteine levels: impact of population-wide folate fortification. Pharmacogenet Genomics 2011;21:426-31.
26. Yang B, Liu Y, Li Y, Fan S, Zhi X, Lu X et al. Geographical distribution of MTHFR C677T, A1298C and MTRR A66G gene polymorphisms in China: findings from 15357 adults of Han nationality. PLoS One 2013;8: e57917.
27. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Grégoire J, Fitzpatrick LA et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998;31:126-33.
28. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;15:2157-62.
29. Tousoulis D, Siasos G, Maniatis K, Oikonomou E, Vlasis K, Papavassiliou AG et al. Novel biomarkers assessing the calcium deposition in coronary artery disease. Curr Med Chem 2012;19:901-20.
30. Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009;202:289-95.
31. Musunuru K, Nasir K, Pandey S, Campbell CC, Carvalho JA, Meneghello R et al. A synergistic relationship of elevated low-density lipoprotein cholesterol levels and systolic blood pressure with coronary artery calcification. Atherosclerosis 2008;200:368-73.
32. Allison MA, Wright CM. A comparison of HDL and LDL cholesterol for prevalent coronary calcification. Int J Cardiol 2004;95:55-60.
33. Folsom AR, Evans GW, Carr JJ, Stillman AE; Atherosclerosis Risk in Communities Study Investigators. Association of traditional and nontraditional cardiovascular risk factors with coronary artery calcification. Angiology 2004;55:613-23.
34. Jöckel KH, Lehmann N, Jaeger BR, Moebus S, Möhlenkamp S, Schmermund A et al. Smoking cessation and subclinical atherosclerosis-results from the Heinz Nixdorf Recall Study. Atherosclerosis. 2009;203:221-7.
35. Li J, Chai S, Tang C, Du J. Homocysteine potentiates calcification of cultured rat aortic smooth muscle cells. Life Sci 2003;74:451-61.
36. Van Campenhout A, Moran CS, Parr A, Clancy P, Rush C, Jakubowski H et al. Role of homocysteine in aortic calcification and osteogenic cell differentiation. Atherosclerosis 2009;202:557-66.